Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TNI medical AG was a German medical device company founded in 2007, specializing in Nasal Highflow (NHF) therapy systems. Its core product, the softFlow technology, delivered high-flow, warmed, and humidified respiratory gases to spontaneously breathing patients with serious pulmonary conditions, notably without requiring external pneumatic systems. TNI medical was acquired by Masimo in Q2 2020, with the acquisition accelerated by increased demand during the COVID-19 pandemic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TNI medical.